LadRx Corporation (LADX)
OTCMKTS · Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Oct 23, 2025, 4:00 PM EDT
LadRx Employees
LadRx had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,247,856
Market Cap
49.51K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | 0 | - |
| Dec 31, 2023 | 2 | -1 | -33.33% |
| Dec 31, 2022 | 3 | 0 | - |
| Dec 31, 2021 | 3 | -1 | -25.00% |
| Dec 31, 2020 | 4 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
LadRx News
- 8 months ago - LadRx Corporation, Inc. to Present at the Virtual Life Science Investor Forum March 13th - GlobeNewsWire
- 11 months ago - LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates - Business Wire
- 1 year ago - LadRx Issues 2024 Update to Shareholders - Business Wire